Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SKP204 is a pseudogene related to the 7SK small nuclear RNA, which in its canonical, functional form (RN7SK) acts as a key regulator of transcriptional elongation by controlling the P-TEFb complex[1][2][3]. However, RN7SKP204 itself is a non-functional genomic element with no protein product, biological function, or direct relevance as a therapeutic target. To clarify, functional 7SK RNA (gene: RN7SK) is significant in the regulation of transcription elongation in the nucleus by sequestering the positive transcription elongation factor b (P-TEFb), affecting global gene expression and being implicated in neuronal function and disease mechanisms[1][2]. However, the pseudogene "RN7SKP204"—as indicated by the suffix "P204"—does not share these properties and is not considered an actionable target in therapeutic contexts.
None (not a functional target)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SK small nuclear pseudogene 204 (RN7SKP204).